Literature DB >> 2549116

Angiotensin II and glucocorticoid release: direct effect at the adrenal level and modulation of the adrenocorticotropin-induced glucocorticoid release.

E Spinedi1, L Aguado, G Basilotta, D Carrizo.   

Abstract

Angiotensin II (A II) stimulates adrenal glomerulosa cells releasing mineralocorticoids; however, little is known about the A II effect on glucocorticoids output. The present study has been designed in order to see if A II could modify in vitro spontaneous and ACTH-induced corticosterone (B) release from both fasciculata-reticularis enriched and total adrenal cells. The results indicate that A II at 10(-12), 10(-11), 10(-10) and 10(-6) M concentrations did not modify basal B production and A II 10(-9), 10(-8) and 10(-7) M decreased basal B production from total adrenal cells. Whereas A II (10(-10)-10(-6) M) stimulated B release from fasciculata-reticularis enriched cells. On the one hand, 10(-8) M A II significantly decreased ACTH-elicited B release from total adrenal cells; effect completely abolished by saralasin (SAR, 10(-8) M), a specific A II receptor blocker. On the other hand, 10(-8) M A II did not modify ACTH-induced B release from fasciculata-reticularis enriched cells. Finally, 10(-10) to 10(-6) M A II and 22 pM ACTH stimulated aldosterone output from total adrenal cells; while, fasciculata-reticularis enriched cells did not secrete any measurable amount of aldosterone under basal condition and after incubation with A II. These data further suggest a regulatory role of A II in the release of glucocorticoids from the adrenal gland.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2549116     DOI: 10.1007/BF03349997

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  31 in total

Review 1.  Peptide hormone receptors.

Authors:  K J Catt; M L Dufau
Journal:  Annu Rev Physiol       Date:  1977       Impact factor: 19.318

2.  The effect of angiotensin II infusion on plasma corticosteroid concentrations in normal man.

Authors:  P A Mason; R Fraser; J J Morton; P F Semple; A Wilson
Journal:  J Steroid Biochem       Date:  1976-10       Impact factor: 4.292

3.  Properties of angiotensin II receptors in the bovine and rat adrenal cortex.

Authors:  H Glossmann; A J Baukal; K J Catt
Journal:  J Biol Chem       Date:  1974-02-10       Impact factor: 5.157

4.  Renin, angiotensin II, and adrenal corticosteroid relationships during sodium deprivation and angiotensin infusion in normotensive and hypertensive man.

Authors:  F A Mendelsohn; C I Johnston; A E Doyle; B A Scoggins; D A Denton; J P Coghlan
Journal:  Circ Res       Date:  1972-11       Impact factor: 17.367

5.  Angiotensin effects on calcium and steroidogenesis in adrenal glomerulosa cells.

Authors:  M E Elliott; F L Siegel; N E Hadjokas; T L Goodfriend
Journal:  Endocrinology       Date:  1985-03       Impact factor: 4.736

6.  Aldosterone production by isolated adrenal glomerulosa cells: stimulation by physiological concentrations of angiotensin II.

Authors:  P Fredlund; S Saltman; K J Catt
Journal:  Endocrinology       Date:  1975-12       Impact factor: 4.736

7.  Angiotensin II and adrenocorticotropin release: mediation by endogenous corticotropin-releasing factor.

Authors:  E Spinedi; G Rodriguez
Journal:  Endocrinology       Date:  1986-09       Impact factor: 4.736

8.  Concurrence of aldosterone, androgen, and cortisol secretion in adrenal venous effluents.

Authors:  M S Huq; D Jespersen; M Pfaff; I R Zucker; M A Kirschner
Journal:  J Clin Endocrinol Metab       Date:  1976-02       Impact factor: 5.958

9.  Efficacy of octa- and heptapeptide antagonists of angiotensin II as inhibitors of angiotensin III binding in the rat adrenal glomerulosa.

Authors:  J G Douglas; M C Khosla; F M Bumpus
Journal:  Endocrinology       Date:  1985-04       Impact factor: 4.736

10.  Angiotensin II and ACTH release: site of action and potency relative to corticotropin releasing factor and vasopressin.

Authors:  E Spinedi; A Negro-Vilar
Journal:  Neuroendocrinology       Date:  1983-12       Impact factor: 4.914

View more
  4 in total

1.  Angiotensin II AT1 receptor blocker candesartan prevents the fast up-regulation of cerebrocortical benzodiazepine-1 receptors induced by acute inflammatory and restraint stress.

Authors:  Enrique Sánchez-Lemus; Masaru Honda; Juan M Saavedra
Journal:  Behav Brain Res       Date:  2012-04-04       Impact factor: 3.332

2.  Analysis of angiotensin II- and ACTH-driven mineralocorticoid functions and omental adiposity in a non-genetic, hyperadipose female rat phenotype.

Authors:  Mario Perelló; Gloria Cónsole; Rolf C Gaillard; Eduardo Spinedi
Journal:  Endocrine       Date:  2010-04-13       Impact factor: 3.633

3.  Nature of changes in adrenocortical function in chronic hyperleptinemic female rats.

Authors:  Mario Perelló; Griselda Moreno; Gisela Camihort; Georgina Luna; Gloria Cónsole; Rolf C Gaillard; Eduardo Spinedi
Journal:  Endocrine       Date:  2004-07       Impact factor: 3.633

4.  Angiotensin II AT1 receptor blockade decreases lipopolysaccharide-induced inflammation in the rat adrenal gland.

Authors:  Enrique Sanchez-Lemus; Yuki Murakami; Ignacio M Larrayoz-Roldan; Armen J Moughamian; Jaroslav Pavel; Tsuyoshi Nishioku; Juan M Saavedra
Journal:  Endocrinology       Date:  2008-06-12       Impact factor: 4.736

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.